Skip to main content
NUTXNutex Health Inc.Hold6.7·$196.53+3.05%
Open full analysis

Nutex Health Inc. (NUTX) Stock Analysis

Catalyst-Driven edge

HoldModerate Confidence

Healthcare · Medical Care Facilities

Hold if already holding. Not a fresh buy at $196.53, but acceptable to hold if already in. Reasons: Thin upside margin: 9.1%; Near 52-week high (2.5% away).

Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network of micro hospitals, specialty... Read more

$196.53+9.1% A.UpsideScore 6.7/10#1 of 36 Medical Care Facilities
QualityF-score9 / 9FCF yield12.48%
Stop $182.77Target $214.37(analyst − 13%)A.R:R 0.6:1
Analyst target$246.40+25.4%5 analysts
$214.37our TP
$196.53price
$246.40mean
$175
$300

Hold if already holding. Not a fresh buy at $196.53, but acceptable to hold if already in. Reasons: Thin upside margin: 9.1%; Near 52-week high (2.5% away). Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Score 6.7/10, moderate confidence.

Passes 7/8 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 26d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Jul 30, 202626d to earnings· next earnings call

Thesis

Rewards
Strong earnings beat streak (3/4)
High-quality business
Attractive valuation
Risks
Thin upside margin: 9.1%
Near 52-week high (2.5% away)
Overbought (RSI 87)

Key Metrics

P/E (TTM)14.4
P/E (Fwd)9.7
Mkt Cap$1.4B
EV/EBITDA3.8
Profit Mgn11.0%
ROE53.6%
Rev Growth2.2%
Beta1.97
DividendNone
Rating analysts9

Quality Signals

Piotroski F9/9MoatNarrow

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

2 floor-breakers·2 ceiling hits

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Bollinger
0.0
Support Resistance
0.7
52w Position
9.5

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Growth Rank
2.0
Value Rank
4.4
Quality Rank
9.4
Superior ROE vs peersBest-in-class margins
GatesA.R:R 0.6 < 1.5@spotMomentum 8.4>=5.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 26d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Aggressive
RSI
87 · Overbought
20D MA 50D MA 200D MAGOLDEN CROSSSupport $130.76Resistance $201.49

Price Targets

$183
$214
A.Upside+9.1%
A.R:R0.6:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! asymmetry at 0.6 (below the engine's 1.5 threshold)@spot

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-07-30 (26d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is NUTX stock a buy right now?

Hold if already holding. Not a fresh buy at $196.53, but acceptable to hold if already in. Reasons: Thin upside margin: 9.1%; Near 52-week high (2.5% away). Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Target $214.37 (+9.1%), stop $182.77 (−7.5%), A.R:R 0.6:1. Score 6.7/10, moderate confidence.

What is the NUTX stock price target?

Take-profit target: $214.37 (+9.1% upside). Target $214.37 (+9.1%), stop $182.77 (−7.5%), A.R:R 0.6:1. Stop-loss: $182.77.

What are the risks of investing in NUTX?

Thin upside margin: 9.1%; Near 52-week high (2.5% away); Overbought (RSI 87).

Is NUTX overvalued or undervalued?

Nutex Health Inc. trades at a P/E of 14.4 (forward 9.7). TrendMatrix value score: 8.6/10. Verdict: Hold.

What do analysts say about NUTX?

9 analysts cover NUTX with a consensus score of 4.1/5. Average price target: $246.

What does Nutex Health Inc. do?Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through...

Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network of micro hospitals, specialty hospitals, and hospital outpatient departments that offer healthcare services, including emergency room care, inpatient care, and behavioural health. It also provides imaging services, such as CT scan, X-ray, MRI, ultrasound, etc.; laboratory services; and onsite inpatient pharmacies. The PHM segment provides management, administrative, and other support services to its affiliated hospitals and physician groups by establishing and operating provider networks, such as independent physician associations (IPAs); and a cloud-based technology platform for IPAs. The Real Estate segment owns and leases land and hospital buildings. Nutex Health Inc. was founded in 2011 and is headquartered in Houston, Texas.

Related stocks: TOI (The Oncology Institute, Inc.) · UHS (Universal Health Services, Inc.) · SRTA (Strata Critical Medical, Inc.) · ARDT (Ardent Health, Inc.) · AVAH (Aveanna Healthcare Holdings Inc)
Home Stocks NUTX

Latest news

No recent news